0.375-mm Mirco-curving Detector
Where Tomorrow's Performance Begins
As Neusoft Medical Systems — a recognized technology leader in detector precision — we bring this expertise to the forefront with the NeuViz Prime Max+ CT. Inheriting the ultra‑high‑definition(UHD) detector technology established in the NeuViz 1024 CT (The world’s first 1024 slices CT)*, the system achieves an exceptional level of detector precision, enabling superior image quality.
Engineered for highly consistent detector coverage, the ultra-fine 0.375 mm detector architecture enables precise, efficient data acquisition — delivering exceptional spatial resolution and reliable image consistency across a broad range of clinical applications.
Our all-in-one intelligent workflow features end-to-end AI integration, guiding the entire scanning process from pre-scan planning to final analysis within a seamless closed loop. By enhancing precision, optimizing workflow efficiency, and reducing unnecessary radiation exposure, NeuAI 3.0 empowers clinicians to focus more on confident, personalized patient care.
Combining outstanding gantry rotation performance with the latest-generation AI-powered whole-heart motion correction technology, iCMC intelligently compensates for cardiac motion,and enables clearer, more consistent cardiac imaging with greater diagnostic confidence.
Consistency across the oncology pathway is becoming a defining challenge. From detection and biopsy to radiotherapy planning, CT plays a central role in ensuring clinical confidence. NeuViz Prime Max+ is introduced to support this continuum — integrating image quality, workflow efficiency, and interventional capability. From visualization to intervention. From imaging to treatment precision. CT is evolving into a platform for clinical decision and action.
Moving from morphological imaging to multi-dimensional analysis, spectral imaging technology brings new perspectives for clinical diagnosis. It lays a solid foundation for early disease detection, improved diagnostic efficiency and accuracy, as well as therapeutic effect evaluation.
Liaoning Public Network Security 21011202000133 15018182-4
Internet Drug Information Service Qualification Certificate
Personal Information and Privacy Protection Policy · Terms of Use
· Site map